Skip to main content

Watson Seeks to Market Generic Vigamox; Alcon Files Suit

Watson Pharmaceuticals confirmed Friday that its Watson Laboratories unit filed an Abbreviated New Drug Application with the FDA and is seeking approval to market a generic version of an antibiotic solution that treats bacterial conjunctivitis. 
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.